RDPAC药品推广行为准则 - IFPMA

如会员公司向医学继续教育活
动和项目提供教学材料时,这些材
料必须公平、全面、客观,其在设
置上应允许不同理论和公认观点的
表达。会员公司提供的教学材料应
包含有助于提升病患福利的医学、
科学或其他信息。
会员公司支持医学继续教育还
须遵守本准则第七条的规定。
第十一条 公司程序与职责分配
11.1 程序
会员公司应建立健全适当的
程序以确保其对相关法律和准则
的遵守,并应以合法合规为目的
对相关程序的实施和内容进行审
查与监控。
11.2 培训
会员公司还应确保相关雇员接
受与其职责相适应的培训。
11.3 药品推广材料的审批
会员公司应配备一名有足够
and therefore financial support from
companies is appropriate.
When companies provide content to
CME activities and programs, such
material must be fair, balanced and
objective, and designed to allow the
expression of diverse theories and
recognized opinions. Content must
consist of medical, scientific or other
information that can contribute to enhancing
patient care.
Companies must follow Article 7 of
the RDPAC Code where applicable.
Article 11 Company Procedures
and Responsibilities
11.1 Procedures
Companies should establish and
maintain appropriate procedures
to ensure compliance with relevant
codes and applicable laws and to
review and monitor all of their activities
and materials in that regard.
11.2 Training
Companies should also ensure that
relevant employees receive training
appropriate to their role.
11.3 Responsibilities for Approving
Promotional Communications
A designated company employee with
31
研
制
开
发
制
药
企
业
协
会